📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: CorMedix

1.1 - Company Overview

CorMedix Logo

CorMedix

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical products targeting cardiac, renal, and infectious diseases. Offers DefenCath, a catheter lock solution with taurolidine and heparin to reduce catheter-related bloodstream infections in adult patients with kidney failure on chronic hemodialysis via central venous catheter.

Products and services

  • Cardiac Disease Therapeutic Development: Architects specialty pharmaceutical products for treating cardiac diseases, directing development toward cardiovascular indications and therapeutic applications, indication-focused development
  • Renal Disease Therapeutic Development: Creates specialty pharmaceutical products for renal disease treatment, incorporating needs of kidney failure patients and dialysis settings, dialysis-focused development
  • DefenCath: A catheter lock formulation combining taurolidine and heparin that reduces catheter-related bloodstream infections in adult kidney failure patients receiving chronic hemodialysis via central venous catheter, catheter-lock combination product

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to CorMedix

Salix Pharmaceuticals Logo

Salix Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceuticals focused on preventing and treating gastrointestinal disorders, licensing, developing, and marketing therapies including XIFAXAN for IBS-D and reducing overt hepatic encephalopathy recurrence; RELISTOR for opioid-induced constipation; TRULANCE for chronic idiopathic constipation and IBS-C; UCERIS for ulcerative colitis; MOVIPREP and PLENVU for colonoscopy bowel preparation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Salix Pharmaceuticals company profile →
Synaptogenix Logo

Synaptogenix

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies in development for neurodegenerative diseases, using bryostatin to promote neuronal health and synaptic regeneration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synaptogenix company profile →
Labopharm Logo

Labopharm

HQ: Canada Website
  • Description: Provider of specialty pharmaceutical solutions that optimize the performance of existing drugs using advanced controlled-release technologies; operates internationally.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Labopharm company profile →
SciFluor Logo

SciFluor

HQ: United States Website
  • Description: Provider of fluorination technologies that improve drug properties, such as metabolic stability and potency.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SciFluor company profile →
Genzyme Logo

Genzyme

HQ: United States Website
  • Description: Provider of biotechnology products and services focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease, operating across four segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery, and Hematologic Oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genzyme company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for CorMedix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to CorMedix

2.2 - Growth funds investing in similar companies to CorMedix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for CorMedix

4.2 - Public trading comparable groups for CorMedix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to CorMedix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About CorMedix

What does CorMedix do?

CorMedix is a provider of specialty pharmaceutical products targeting cardiac, renal, and infectious diseases. Offers DefenCath, a catheter lock solution with taurolidine and heparin to reduce catheter-related bloodstream infections in adult patients with kidney failure on chronic hemodialysis via central venous catheter.

Who are CorMedix's competitors?

CorMedix's competitors and similar companies include Salix Pharmaceuticals, Synaptogenix, Labopharm, SciFluor, and Genzyme.

Where is CorMedix headquartered?

CorMedix is headquartered in United States.

How many employees does CorMedix have?

CorMedix has 1,000 employees 🔒.

When was CorMedix founded?

CorMedix was founded in 2010 🔒.

What sector and industry vertical is CorMedix in?

CorMedix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for CorMedix

Who are the top strategic acquirers in CorMedix's sector and industry

Top strategic M&A buyers and acquirers in CorMedix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for CorMedix?

Top strategic M&A buyers groups and sectors for CorMedix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in CorMedix's sector and industry vertical

Which are the top PE firms investing in CorMedix's sector and industry vertical?

Top PE firms investing in CorMedix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in CorMedix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in CorMedix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in CorMedix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to CorMedix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in CorMedix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for CorMedix?

The key public trading comparables and valuation benchmarks for CorMedix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for CorMedix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for CorMedix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in CorMedix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for CorMedix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in CorMedix's' sector and industry vertical?

Access recent funding rounds and capital raises in CorMedix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for CorMedix